New Drug Delivery Method Targets Gut, Reduces IBD Medication Doses by Up to 10 Times- Study
Advertisement
A new drug delivery technique, GlycoCaging, could transform the treatment of inflammatory bowel disease (IBD), allowing medication to be delivered directly to the gut at much lower doses. The proof-of-concept study, published in Science, demonstrates that this method can effectively target the lower gut in mice, using up to 10 times less medication than current therapies.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.